When targeting HIF pathways, HIF-1 seems to be a friend in the treatment of ulcerative colitis but a foe in other autoimmune-mediated pathogeneses such as Crohn disease, systemic lupus erythematosus, rheumatoid arthritis, and psoriasis [281]. This evidence concerns the gene HIF1A and ulcerative colitis.